ATLASOptimizeRx (OPRX) earnings date: Nov 11, 2026
OptimizeRx (OPRX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, after the close. Analysts expect EPS of $0.07.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on OPRX
| Last price | $9.39 (+0.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.0% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 3 reports |
These figures come from the same calibrated model and valuation as the OptimizeRx stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
OptimizeRx reports on Nov 11, 2026. One email the day before, with ATLAS’s read on OptimizeRx. You can switch it off at any time.
Alert me before OPRX reportsFree to start. Creating an account takes under a minute.
Notify me when OptimizeRx reports
Track OPRX free Add OptimizeRx to a free ATLAS watchlist and see its next report date in one place.
OPRX earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.07 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 3 reports) | 3 of 3 (100%) |
| Average EPS surprise | +65.9% |
| Average move around a report | ±10.0% (last 3) |
| Sector | Healthcare · Health Information Services |
OptimizeRx earnings history: last 3 reports
OptimizeRx last reported on Aug 12, 2026: EPS of $0.16 against an estimate of $0.11 (+45.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | $0.11 | $0.16 | +45.5% | Beat | +26.9% |
| Jul 28, 2026 | $0.87 | $0.89 | +2.3% | Beat | -0.2% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | +2.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for OPRX
See the fair value, the probability range and the earnings history of OptimizeRx on its ATLAS page.
OptimizeRx (OPRX) stock analysisPlans from €3.99 a month.
OptimizeRx earnings: frequently asked questions
When does OptimizeRx (OPRX) report earnings?
OptimizeRx is scheduled to report on Wednesday, November 11, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for OPRX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.07 per share (USD). Estimates can change before the report.
How often does OPRX beat earnings estimates?
Of its last 3 reports with a recorded result, OptimizeRx beat the EPS estimate 3 times; the average surprise was +65.9%. Past results do not predict the next one.
How much does OPRX move around earnings?
Over its last 3 reports the stock moved an average of 10.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 3 times.
Did OptimizeRx beat earnings estimates last quarter?
OptimizeRx last reported on Aug 12, 2026: EPS of $0.16 against an estimate of $0.11 (+45.5% surprise), a beat.
How much does OPRX usually move in a day?
On a normal trading day the ATLAS model puts OPRX’s one-day range at about ±3.0%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer